SCHEMBL26031567

SCHEMBL26031567

c1ccc(-c2cccc3c2sc2ccccc23)c(-c2ccc(N(c3ccc(-c4cccc5oc6ccccc6c45)cc3)c3ccc(-c4cccc5oc6ccccc6c45)cc3)cc2)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.42
▸ PARP14 Q460N5 1/20 0.38
▸ PRKDC P78527 7/20 0.37
▸ PIK3CD O00329 2/20 0.35
▸ PIK3CB P42338 2/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ BRDT Q58F21 1/20 0.35
▸ BACE1 P56817 1/20 0.32
▸ LIMK1 P53667 1/20 0.30
▸ GPR3 P46089 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ PAX8 Q06710 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26031731 0.96 ALOX5 (0.39) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL26031554 0.95 ALOX5 (0.47) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL26031557 0.94 ALOX5 (0.46) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL26031714 0.91 ALOX5 (0.43) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL26031653 0.90 ALOX5 (0.43) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL24710228 0.89 ALOX5 (0.47) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL25577660 0.88 ALOX5 (0.35) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL25577680 0.87 ALOX5 (0.39) ALOX5PARP14PRKDCLIMK1
SCHEMBL22161243 0.86 ALOX5 (0.42) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL22161236 0.86 ALOX5 (0.42) ALOX5PARP14PRKDCPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048242-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-23 — — US disclosed
US-12048242-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-07-23 — — US disclosed
US-11744149-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11744149-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device RER1, LEF1, MLX ALOX5 1467/4885PARP14 3268/4885PRKDC 4864/4885
US-12048242-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device RER1, LEF1, MLX ALOX5 1467/4885PARP14 3268/4885PRKDC 4864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback